Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bank China Construction Bank Indonesia Tbk. (MCOR) vs Merck Tbk. (MERK) Price & Performance

Bank China Construction Bank Indonesia Tbk.Trade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Bank China Construction Bank Indonesia Tbk. vs Merck Tbk. — how do they compare? Bank China Construction Bank Indonesia Tbk. trades at Rp69 (market cap 2.59T, 1.91M 24h volume), while Merck Tbk. trades at Rp3,900 (market cap 1.76T, 63K 24h volume). The key difference: Bank China Construction Bank Indonesia Tbk. is the larger of the two by market cap, and Bank China Construction Bank Indonesia Tbk. is more actively traded (1.91M versus 63K). Which is the better fit depends on your goals.

MCORMERK
Market Cap
2.59T1.76T
Volume
1.91M63K
Lot
19.07K630
Turnover
132.14M243.97M
Average Price
69.293,872.46
Value
132.14M243.97M
Indicative Equilibrium Price
693,900
Indicative Equilibrium Volume
1131

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MCOR
View details
MERK
View details

About Bank China Construction Bank Indonesia Tbk.

PT Bank Multicor (Bank) was established under its original name of PT Multinational Finance Corporation base on notarial deed No.4 of Mr Bagijo, S.H, dated on Apr 2, 1974. The Company’s articles of association has been amended several times, most recently by notarial deed No. 143 of Eliwati Tjitra, S.H., dated Mar 21, 2007, concerning among others, the change in the Company’s name, Anggaran Dasar and public offering. The Bank's name was changed to PT Bank Windu Kentjana International Tbk.

Read more on MCOR

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK